CN107137768A - 一种脱细胞羊膜粉的制备方法 - Google Patents

一种脱细胞羊膜粉的制备方法 Download PDF

Info

Publication number
CN107137768A
CN107137768A CN201710237111.8A CN201710237111A CN107137768A CN 107137768 A CN107137768 A CN 107137768A CN 201710237111 A CN201710237111 A CN 201710237111A CN 107137768 A CN107137768 A CN 107137768A
Authority
CN
China
Prior art keywords
amnion
hours
cell
powder
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201710237111.8A
Other languages
English (en)
Other versions
CN107137768B (zh
Inventor
刘洪�
杨熙
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Suzhou Nuopu Regenerative Medicine Co Ltd
Original Assignee
Suzhou Nuopu Regenerative Medicine Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suzhou Nuopu Regenerative Medicine Co Ltd filed Critical Suzhou Nuopu Regenerative Medicine Co Ltd
Priority to CN201710237111.8A priority Critical patent/CN107137768B/zh
Publication of CN107137768A publication Critical patent/CN107137768A/zh
Application granted granted Critical
Publication of CN107137768B publication Critical patent/CN107137768B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3687Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by the use of chemical agents in the treatment, e.g. specific enzymes, detergents, capping agents, crosslinkers, anticalcification agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/50Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/982Reproductive organs; Embryos, Eggs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0057Ingredients of undetermined constitution or reaction products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A61L27/3691Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment characterised by physical conditions of the treatment, e.g. applying a compressive force to the composition, pressure cycles, ultrasonic/sonication or microwave treatment, lyophilisation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/30Compounds of undetermined constitution extracted from natural sources, e.g. Aloe Vera
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/412Tissue-regenerating or healing or proliferative agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00Materials or treatment for tissue regeneration
    • A61L2430/40Preparation and treatment of biological tissue for implantation, e.g. decellularisation, cross-linking

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Molecular Biology (AREA)
  • Botany (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Reproductive Health (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pregnancy & Childbirth (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Materials Engineering (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

本发明公开了一种脱细胞羊膜粉的制备方法,包括1)、将羊膜清洗、剪碎;2)、在4℃的振荡器中洗涤12~24小时;3)、在4℃的振荡器中用1%的Triton x‑100和氢氧化铵洗涤1~3天;4)、在4℃的振荡器中用去离子水洗涤12~24小时;然后用PBS洗涤12~24小时;5)、‑80℃保存24小时,然后冻干;6)、低温环境下研磨成粉7)、消毒后‑80℃储存。本发明采用相对温和的脱细胞方法去除了羊膜的细胞并进行灭菌处理,整个过程中严格控制低温环境,对羊膜中的活性物质进行有效的保护;所制得的冷冻羊膜粉末可以制成羊膜胶或喷雾等多种形式,更有利于创面利用胶原与蛋白小分子,为创面愈合提供更有效的营养支持,其生长因子等活性物质可持续促上皮化。

Description

一种脱细胞羊膜粉的制备方法
技术领域
本发明涉及一种脱细胞羊膜粉的制备方法。
背景技术
羊膜是胎盘的最内层,包裹着羊水的光滑的、无血管、神经及淋巴、具有弹性一层生物半透膜;羊膜中存在Ⅰ、Ⅲ、Ⅳ、Ⅴ、Ⅶ型胶原和纤维粘连蛋白、层粘连蛋白等多种蛋白成分及一些生长因子,如表皮细胞生长因子(EGF)、成纤维细胞生长因子(FGF)、转化生长因子(TGF)等,这些生长因子能促进上皮细胞的增殖、迁移、分化,增强上皮细胞的粘附性,促上皮化,减轻瘢痕;
羊膜可促进结膜干细胞分化为结膜上皮细胞、促进结膜上皮向角膜上皮转化,促进角膜缘干细胞增殖及提供一个有助于其生长的微环境,促进角膜上皮细胞移行、促进角膜基质胶原纤维增生、抑制结膜下纤维组织增生、抑制新生血管增生,具有抗炎、抗菌等功能;羊膜上皮细胞不表达hla-a、b、c、dr抗原或β2微球蛋白,表达ib抗原、限制ia抗原,这些特点使羊膜表达低抗原性;羊膜中含有多种胶原及蛋白成分,可以为创面愈合提供丰富的营养支持;
羊膜的生物学特性和医学研究均证明羊膜作为敷料应用于创面时相比其他很多人工合成敷料具有明显的优势;人羊膜上皮细胞不表达hla-a、b、c、dr抗原或β2微球蛋白,表达ib抗原、限制ia抗原,这些特点使羊膜表达低抗原性;羊膜的结构与羊膜中的胶原和多种活性物质不仅可以使羊膜发挥较好的屏障作用,而且还具有抗菌消炎、促愈合、减轻挛缩等作用;羊膜内的胶原、蛋白成分和活性因子,在作为敷料应用于伤口时营养成份的利用和活性因子的释放率可以加快创面愈合速度和提高创面愈合质量。但新鲜生物羊膜为单层结构,厚度薄,易卷曲折叠,滑动脱落,有效作用时间短,在应用创面时会有一定局限性;人们对新鲜羊膜做处理使其在保留天然优良性能的同时改良缺陷和不同,使其具有更大价值。
专利CN103114073B公布了一种人羊膜的脱细胞方法,采用表面活性剂TritonX-100、胰脂酶、DNA酶结合作用,属于化学与生物方法相结合的较彻底的脱细胞方法,但这类方法形成会导致蛋白成分和生长因子的大量流失,可做为较理想的组织工程的支架材料,但作为敷料应用于创面时的作用会大大下降;
专利CN200510046856.3公开了一种干燥活性羊膜的制备方法,可以将新鲜羊膜脱细胞后冷冻干燥,有延长了羊膜的保质期,随取随用的优点,但仍然是单层结构,厚度薄,质感脆,在不规则创面的应用上的适应性差。
发明内容
本发明要解决的技术问题是克服现有的羊膜的脱细胞方法不够温和,同时具有抗原性和其他来源于供体的风险的缺陷,提供一种能适应不同创面的脱细胞羊膜粉的制备方法。
为了解决上述技术问题,本发明提供了如下的技术方案:
1、一种脱细胞羊膜粉的制备方法,其特征在于,包括以下步骤:
1)、将新鲜的羊膜清洗,去除表面血迹,剪成碎片;新鲜的羊膜清洗时使用无菌水、无菌盐水或培养基;可将羊膜剪成面积为5×5cm的碎片,可以用无菌剪刀和镊子,手术刀或切片机,也可以按用途更改尺寸;新鲜的羊膜取自新鲜的胎盘,可以是人源,也可以是动物源;
2)、在4℃的振荡器中用去离子水洗涤12~24小时,每4~6小时更换一次去离子水;
3)、在4℃的振荡器中用质量分数为0.1~2%的Triton x-100和氢氧化铵混合液洗涤1~3天,每天更换洗涤液;本步骤还可用细胞刮刀等器具轻刮羊膜表面后震荡细胞等机械方法达到脱去羊膜上皮细胞的目的。
4)、在4℃的振荡器中用去离子水洗涤12~24小时,每4~6小时更换一次去离子水;然后用PBS洗涤12~24小时,每4~6小时更换PBS;
5)、-80℃保存24小时后进行冻干,将泥浆状支架置于一次性无菌平皿中,转移至冻干机冷阱中预冷2~5小时,开启真空冻干24~48小时,无菌收料;还可以采用将羊膜碎片放在无水乙醇或干冰中迅速冷冻,再放在冷冻干燥器中以-20℃冻干直至干燥的方法实现;
6)、将羊膜碎片放入钢桶中浸入液氮中预冷后,钢桶放入冷冻研磨机中研磨频率为40~80Hz,研磨时间为20~60s,形成粒径<250um的羊膜粉。
7)、消毒后-80℃储存备用。优选的,采用15~30KGy的γ射线辐照灭菌。
进一步的,振荡器的转数为120~150rpm。
进一步的,步骤3)中除Triton X-100和氢氧化铵的方法外,还可用细胞刮刀等器具轻刮羊膜表面后震荡细胞等机械方法达到脱去羊膜表层上皮细胞的目的。
进一步的,步骤5)中将冷冻后的羊膜碎片放入冻干机冷阱中预冷2-5小时,开启真空冻干24~48小时。
进一步的,步骤2)-7)中严格控制不高于4℃的低温环境,冻干、研磨工艺过程中控制低温环境以保护羊膜中的活性因子。
进一步的,以步骤7)中的脱细胞羊膜粉末为中间产品,消化后制成可溶羊膜、进一步交联后制成羊膜胶、喷雾、药膏等其他形式添加到辅料、药物中应用或直接应用于创面。
进一步的,以步骤7)中的脱细胞羊膜粉末与胶原、透明质酸、壳聚糖等生物大分子聚合物及PPO、PEO等合成聚合物或其他材料交联应用于组织工程或其他领域。
本发明与现有技术相比,具备如下优点:
(1)本发明采用相对温和的脱细胞方法对羊膜进行脱细胞并进行灭菌处理,避免了羊膜的免疫原性和其他来源于供体的风险,这使脱细胞后的羊膜在应用于人体时避免了免疫排斥的问题;
(2)洗涤、脱细胞和研磨工艺过程中严格控制低温环境,研磨时间短,减少过程中活性物质的损失,对羊膜中包括人表皮生长因子(EGF)、人成纤维细胞生长因子(FGF)人肝细胞生长因子(HGF)、人血管内皮生长因子(VEGF)、人神经生长因子(NGF)、胰岛素样生长因子(IGF)等生长因子在内的各种活性物质进行有效的保护(如表一),胶原蛋白等分子和生长因子等活性因子的保留比较充分,可以为创面愈合提供更有效的营养支持,其生长因子等活性物质可持续促上皮化,预防和减轻炎症以及加速愈合;
(3)与厚度薄,易卷曲与移动,在创面上作用时间短,且对不规则创面的应用上有一定的局限性的单层羊膜相比,所制得的冷冻羊膜粉及羊膜胶或喷雾,可以应用于不规则形状和深度伤口的治疗或添加到辅料、药物中应用,适应性广泛;
(4)本发明制得的羊膜粉末粒径小,更有利于创面利用胶原与蛋白小分子,为创面愈合提供更有效的营养支持,其生长因子等活性物质可持续促上皮化,加速创面愈合;抑制新生血管和纤维组织增生,减少瘢痕生成,增加愈合质量;
(5)本发明制得的冻干羊膜可作为一种支架材料与胶原、透明质酸、壳聚糖等生物大分子聚合物及PPO、PEO等合成聚合物或其他材料交联应用于组织工程或其他领域。冻干脱细胞羊膜粉中含有丰富的胶原和各种生长因子,可作为制成护肤保养品的原材料使用。
具体实施方式
以下对本发明的优选实施例进行说明,应当理解,此处所描述的优选实施例仅用于说明和解释本发明,并不用于限定本发明。
一种脱细胞羊膜粉的制备方法,其特征在于,包括以下步骤:
1)、收集新鲜的人类胎盘,将羊膜从胎盘内侧剥离,将新鲜的羊膜清洗,去除表面血迹,剪成碎片;新鲜的羊膜清洗时使用无菌水、无菌盐水或培养基;可将羊膜剪成面积为5×5cm的碎片,可以用无菌剪刀和镊子,手术刀或切片机,也可以按用途更改尺寸;新鲜的羊膜取自新鲜的胎盘,可以是人源,也可以是动物源;
2)、在4℃的振荡器中用去离子水洗涤12~24小时,每4~6小时更换一次去离子水;
3)、在4℃的振荡器中用质量分数为0.1~2%的Triton x-100和氢氧化铵混合液洗涤1~3天,每天更换洗涤液;本步骤还可以使用还可以采用轻刮羊膜表面配合震荡羊膜等机械方法来实现脱细胞的目的;
4)、在4℃的振荡器中用去离子水洗涤12~24小时,每4~6小时更换一次去离子水;然后用PBS洗涤12~24小时,每4~6小时更换PBS;
5)、-80℃保存24小时后冻干,将泥浆状支架置于一次性无菌平皿中,转移至冻干机冷阱中预冷2~5小时,开启真空冻干24~48小时,无菌收料;此外,还可以采用将羊膜碎片放在无水乙醇或干冰中迅速冷冻,再放在冷冻干燥器中以-20℃冻干直至干燥的方法实现;
6)、将羊膜碎片放入钢桶中浸入液氮中预冷后,钢桶放入冷冻研磨机中研磨频率为40~80Hz,研磨时间为20~60s,形成粒径<250um的羊膜粉。
7)、消毒后-80℃储存备用。优选的,采用15~30KGy的γ射线或电子束辐照灭菌。
脱细胞羊膜粉蛋白含量分析实验:
比色法来衡量总蛋白,胶原蛋白,弹性蛋白和糖胺聚糖含量;
ELISA试剂盒测定生长因子含量;包括:人表皮生长因子(EGF)、人成纤维细胞生长因子(FGF)、人血管内皮生长因子(VEGF)、人肝细胞生长因子(HGF)。
结果如下表所示:
表一、脱细胞羊膜粉的蛋白含量及细胞因子含量
名称 含量(mg/g) 名称 含量(ng/g)
总蛋白 163.6 EGF 11.393
弹性蛋白 30.44 FGF 1.529
胶原蛋白 105.2 VEGF 4.84
糖胺聚糖 0.82 HGF 26.791
对本发明中蛋白含量和几种生长因子的含量检测结果显示,按本发明的方法制作的羊膜粉末对胶原蛋白等分子和生长因子等活性因子的保留比较充分,可以为创面愈合提供更有效的营养支持,其生长因子等活性物质可持续促上皮化,加速创面的愈合。
最后应说明的是:以上所述仅为本发明的优选实施例而已,并不用于限制本发明,尽管参照前述实施例对本发明进行了详细的说明,对于本领域的技术人员来说,其依然可以对前述各实施例所记载的技术方案进行修改,或者对其中部分技术特征进行等同替换。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。

Claims (9)

1.一种脱细胞羊膜粉的制备方法,其特征在于,包括以下步骤:
1)、将新鲜的羊膜清洗,去除表面血迹,剪成碎片;
2)、在4℃的振荡器中用去离子水洗涤12~24小时,每4~6小时更换一次去离子水;
3)、在4℃的振荡器中用质量分数为0.1~2%的Triton X-100和氢氧化铵混合液洗涤1~3天,每天更换洗涤液;
4)、在4℃的振荡器中用去离子水洗涤12~24小时,每4~6小时更换一次去离子水;然后用PBS洗涤12~24小时,每4~6小时更换PBS;
5)、-80℃保存24小时后冻干,将泥浆状支架置于一次性无菌平皿中,注意无菌操作,转移至冻干机冷阱中预冷,开启真空,按照预设的冻干工艺冻干,无菌收料。
6)、将冻干后的羊膜碎片放入钢桶中浸入液氮中预冷后,钢桶放入冷冻研磨机中研磨成粉;
7)、将羊膜粉辐照灭菌后-80℃储存备用。
2.如权利要求1或2所述的脱细胞羊膜粉的制备方法,其特征在于,步骤2)-4)中温度保持在4℃,振荡器的转数为120~150rpm。
3.如权利要求1所述的脱细胞羊膜的制备方法,其特征在于,将所得5)所得的无菌脱细胞冻干羊膜碎片放入液氮中预冷2min后在冷冻研磨机中,研磨频率为40~80Hz,研磨时间为20~60s,形成粒径<250um的羊膜粉。
4.如权利要求1或4所述的脱细胞羊膜粉的制备方法,其特征在于,所述步骤6)中采用15~30KGy的γ射线或电子束辐照灭菌。
5.如权利要求1所述的脱细胞羊膜粉的制备方法,其特征在于,步骤3)中除Triton X-100和氢氧化铵的方法外,还可用器具轻刮羊膜表面后震荡细胞达到脱去羊膜表层上皮细胞的目的。
6.如权利要求1所述的脱细胞羊膜粉的制备方法,其特征在于,步骤5)中将冷冻后的羊膜碎片放入冻干机冷阱中预冷2-5小时,开启真空冻干24~48小时。
7.如权利要求1所述的脱细胞羊膜粉的制备方法,其特征在于,步骤2)-7)中严格控制不高于4℃的低温环境,冻干、研磨工艺过程中控制低温环境以保护羊膜中的活性因子。
8.如权利要求1所述的脱细胞羊膜粉的制备方法,其特征在于,以步骤7)中的脱细胞羊膜粉末为中间产品,消化后制成可溶羊膜、进一步交联后制成羊膜胶、喷雾、药膏添加到辅料、药物中应用或直接应用于创面。
9.如权利要求1所述的脱细胞羊膜粉的制备方法,其特征在于,以步骤7)中的脱细胞羊膜粉末与生物大分子聚合物及合成聚合物交联应用于组织工程领域。
CN201710237111.8A 2017-04-12 2017-04-12 一种脱细胞羊膜粉的制备方法 Active CN107137768B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710237111.8A CN107137768B (zh) 2017-04-12 2017-04-12 一种脱细胞羊膜粉的制备方法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710237111.8A CN107137768B (zh) 2017-04-12 2017-04-12 一种脱细胞羊膜粉的制备方法

Publications (2)

Publication Number Publication Date
CN107137768A true CN107137768A (zh) 2017-09-08
CN107137768B CN107137768B (zh) 2020-07-07

Family

ID=59775081

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710237111.8A Active CN107137768B (zh) 2017-04-12 2017-04-12 一种脱细胞羊膜粉的制备方法

Country Status (1)

Country Link
CN (1) CN107137768B (zh)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109288867A (zh) * 2018-10-26 2019-02-01 上海慧存医疗科技有限公司 一种复合羊膜粉制剂的制备方法
CN110575567A (zh) * 2019-08-20 2019-12-17 苏州诺普再生医学有限公司 一种支架复合材料及其制备方法、应用
CN112915261A (zh) * 2021-02-03 2021-06-08 英中再生医学(山东)有限公司 一种化学交联脱细胞羊膜支架的制备方法
CN113274354A (zh) * 2021-04-27 2021-08-20 胡竹林 风干羊膜粉及应用
CN113599578A (zh) * 2021-08-11 2021-11-05 上海海洋大学 含dHAM的复合静电纺丝纤维膜及其制备方法和应用
CN114225103A (zh) * 2021-12-31 2022-03-25 湖北省银丰鼎诚生物工程有限公司 一种羊膜-氧化石墨烯水凝胶医用生物敷料
CN114712562A (zh) * 2022-04-08 2022-07-08 上海亚朋生物技术有限公司 一种脱细胞冻干羊膜产品的制备工艺
CN115227862A (zh) * 2022-04-20 2022-10-25 杭州倍荣生物科技有限公司 治疗用水凝胶敷料的制备与使用
CN115463259A (zh) * 2022-10-24 2022-12-13 广州远想医学生物技术有限公司 一种脱细胞生物膜的加工方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040048796A1 (en) * 2002-03-26 2004-03-11 Hariri Robert J. Collagen biofabric and methods of preparation and use therefor
CN102225217A (zh) * 2011-06-23 2011-10-26 天津世纪康泰生物医学工程有限公司 脱细胞干燥活性羊膜的制备方法
CN102552979A (zh) * 2012-01-20 2012-07-11 陕西瑞盛生物科技有限公司 一种角膜板层材料的制备方法
CN105497982A (zh) * 2015-12-09 2016-04-20 北京大学第三医院 一种脱细胞真皮基质的用途及其使用方法
US20160199417A1 (en) * 2014-06-15 2016-07-14 Amnio Technology Llc Method of treatment utilizing an acellular amnion derived therapeutic composition
CN105963785A (zh) * 2016-06-22 2016-09-28 上海市第六人民医院 一种基于脂肪干细胞膜片的脱细胞基质材料及其制备方法

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040048796A1 (en) * 2002-03-26 2004-03-11 Hariri Robert J. Collagen biofabric and methods of preparation and use therefor
CN1791331A (zh) * 2002-03-26 2006-06-21 人类起源公司 胶原生物织物以及其制备和使用方法
CN102225217A (zh) * 2011-06-23 2011-10-26 天津世纪康泰生物医学工程有限公司 脱细胞干燥活性羊膜的制备方法
CN102552979A (zh) * 2012-01-20 2012-07-11 陕西瑞盛生物科技有限公司 一种角膜板层材料的制备方法
US20160199417A1 (en) * 2014-06-15 2016-07-14 Amnio Technology Llc Method of treatment utilizing an acellular amnion derived therapeutic composition
CN105497982A (zh) * 2015-12-09 2016-04-20 北京大学第三医院 一种脱细胞真皮基质的用途及其使用方法
CN105963785A (zh) * 2016-06-22 2016-09-28 上海市第六人民医院 一种基于脂肪干细胞膜片的脱细胞基质材料及其制备方法

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
何越等: "人羊膜脱细胞基质填充材料的生物相容性及动物有效性研究", 《中国美容整形外科杂志》 *

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109288867A (zh) * 2018-10-26 2019-02-01 上海慧存医疗科技有限公司 一种复合羊膜粉制剂的制备方法
CN110575567A (zh) * 2019-08-20 2019-12-17 苏州诺普再生医学有限公司 一种支架复合材料及其制备方法、应用
CN112915261A (zh) * 2021-02-03 2021-06-08 英中再生医学(山东)有限公司 一种化学交联脱细胞羊膜支架的制备方法
CN113274354A (zh) * 2021-04-27 2021-08-20 胡竹林 风干羊膜粉及应用
CN113599578A (zh) * 2021-08-11 2021-11-05 上海海洋大学 含dHAM的复合静电纺丝纤维膜及其制备方法和应用
CN113599578B (zh) * 2021-08-11 2022-10-04 上海海洋大学 含dHAM的复合静电纺丝纤维膜及其制备方法和应用
CN114225103A (zh) * 2021-12-31 2022-03-25 湖北省银丰鼎诚生物工程有限公司 一种羊膜-氧化石墨烯水凝胶医用生物敷料
CN114712562A (zh) * 2022-04-08 2022-07-08 上海亚朋生物技术有限公司 一种脱细胞冻干羊膜产品的制备工艺
CN115227862A (zh) * 2022-04-20 2022-10-25 杭州倍荣生物科技有限公司 治疗用水凝胶敷料的制备与使用
CN115463259A (zh) * 2022-10-24 2022-12-13 广州远想医学生物技术有限公司 一种脱细胞生物膜的加工方法
CN115463259B (zh) * 2022-10-24 2023-11-07 广州远想医学生物技术有限公司 一种脱细胞生物膜的加工方法

Also Published As

Publication number Publication date
CN107137768B (zh) 2020-07-07

Similar Documents

Publication Publication Date Title
CN107137768A (zh) 一种脱细胞羊膜粉的制备方法
Arrizabalaga et al. Human amniotic membrane: a versatile scaffold for tissue engineering
Fairbairn et al. The clinical applications of human amnion in plastic surgery
KR100999247B1 (ko) 콜라겐 생구조물 및 그 제조방법 및 용도
Chopra et al. Amniotic membrane: a novel material for regeneration and repair
KR102284982B1 (ko) 비-포유류 조직으로부터의 세포제거된 생체재료
Maver et al. Advanced therapies of skin injuries
WO2009044408A1 (en) A treated amniotic membrane and method of treating amniotic membrane
KR20080032212A (ko) 시트형 조성물
US20150352157A1 (en) Wound Dressing Nanomesh Impregnated with Human Umbilical Cord Wharton&#39;s Jelly Stem Cells
Zhang et al. Development of a visible light, cross-linked GelMA hydrogel containing decellularized human amniotic particles as a soft tissue replacement for oral mucosa repair
WO2011094965A1 (zh) 一种制备组织工程角膜的方法
KR20170116664A (ko) 수포성 표피박리증 완화 또는 개선용 중간엽줄기세포-하이드로겔-생분해성 또는 중간엽줄기세포-하이드로겔-비분해성 지지체 조성물
CN109157676A (zh) 一种重塑复合生物羊膜的制备方法
CN114177340A (zh) 一种可降解的胎盘脱细胞多孔海绵基质敷料的制备和应用
Doudi et al. Applications of acellular human amniotic membrane in regenerative medicine
JP2002504412A (ja) 生きたキメラ皮膚置換体
CN110960729B (zh) 一种多糖改性的无细胞基质复合材料、制备及应用
KR101365065B1 (ko) 창상 치료용 감귤 유래 박테리아 셀룰로오스 겔 및 이를 함유하는 드레싱 제재
Kumaresan et al. Development of Human Umbilical cord based scaffold for tissue engineering application
CN113101415A (zh) 一种细胞结构完整降解可控的生物羊膜及其制备方法
KR100644078B1 (ko) 양막과 생분해성 고분자로 구성된 이식용 진피대체물,이의 제조방법 및 용도
Albannaa et al. Histopathological evaluation of human amniotic membrane effect on early stage healing of induced defects in rabbit's oral mucosa
CN105214129B (zh) 一种生物敷料的制备方法及生物敷料
US20230310707A1 (en) Porcine Scaffolds and Methods of Preparation

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant